These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33791038)

  • 1. Scientific and technical guidance for the preparation and presentation of a health claim application (Revision 3).
    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
    EFSA J; 2021 Mar; 19(3):e06554. PubMed ID: 33791038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scientific and technical guidance for the preparation and presentation of a health claim application (Revision 2).
    ; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Sjödin A; Stern M; Tomé D; Van Loveren H; Vinceti M; Willatts P; Martin A; Strain JJ; Heng L; Valtueña Martínez S; Siani A
    EFSA J; 2017 Jan; 15(1):e04680. PubMed ID: 32625270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidance on the preparation and presentation of applications for exemption from mandatory labelling of food allergens and/or products thereof pursuant to Article 21 (2) of Regulation (EU) No 1169/2011.
    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
    EFSA J; 2021 Mar; 19(3):e06543. PubMed ID: 33791035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scientific and technical guidance on foods for special medical purposes in the context of Article 3 of Regulation (EU) No 609/2013.
    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
    EFSA J; 2021 Mar; 19(3):e06544. PubMed ID: 33791036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. General scientific guidance for stakeholders on health claim applications (Revision 1).
    EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
    EFSA J; 2021 Mar; 19(3):e06553. PubMed ID: 33791037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidance on the preparation and submission of an application for authorisation of a novel food in the context of Regulation (EU) 2015/2283 (Revision 1)
    ; Nutrition ; Nda A; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Siani A; Sjödin A; Stern M; Tomé D; Vinceti M; Willatts P; Engel KH; Marchelli R; Pöting A; Poulsen M; Salminen S; Schlatter J; Arcella D; Gelbmann W; de Sesmaisons-Lecarré A; Verhagen H; van Loveren H
    EFSA J; 2021 Mar; 19(3):e06555. PubMed ID: 33791039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidance on the preparation and submission of the notification and application for authorisation of traditional foods from third countries in the context of Regulation (EU) 2015/2283 (Revision 1).
    ; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Siani A; Sjödin A; Stern M; Tomé D; Vinceti M; Willatts P; Engel KH; Marchelli R; Pöting A; Poulsen M; Schlatter J; Gelbmann W; de Sesmaisons-Lecarré A; Verhagen H; van Loveren H
    EFSA J; 2021 Mar; 19(3):e06557. PubMed ID: 33791041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scientific and technical guidance for the preparation and presentation of a dossier for evaluation of an infant and/or follow-on formula manufactured from protein hydrolysates (Revision 1).
    ; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Sjödin A; Stern M; Tomé D; Loveren HV; Vinceti M; Willatts P; Fewtrell M; Przyrembel H; Titz A; Martínez SV
    EFSA J; 2021 Mar; 19(3):e06556. PubMed ID: 33791040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Scientific and technical guidance for the preparation and presentation of an application for authorisation of an infant and/or follow-on formula manufactured from protein hydrolysates.
    ; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Sjödin A; Stern M; Tomé D; Van Loveren H; Vinceti M; Willatts P; Fewtrell M; Przyrembel H; Titz A; Valtueña Martínez S
    EFSA J; 2017 May; 15(5):e04779. PubMed ID: 32625485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidance on safety evaluation of sources of nutrients and bioavailability of nutrient from the sources (Revision 1).
    ; Younes M; Aggett P; Aguilar F; Crebelli R; Dusemund B; Filipič M; Frutos MJ; Galtier P; Gundert-Remy U; Kuhnle GG; Lambré C; Leblanc JC; Lillegaard IT; Moldeus P; Mortensen A; Oskarsson A; Stankovic I; Waalkens-Berendsen I; Woutersen RA; Wright M; Di Domenico A; Fairweather-Tait S; McArdle HJ; Smeraldi C; Gott D
    EFSA J; 2021 Mar; 19(3):e06552. PubMed ID: 33815621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scientific Guidance for the submission of dossiers on Food Enzymes.
    ; Lambré C; Barat Baviera JM; Bolognesi C; Cocconcelli PS; Crebelli R; Gott DM; Grob K; Lampi E; Mengelers M; Mortensen A; Rivière G; Steffensen IL; Tlustos C; Van Loveren H; Vernis L; Zorn H; Glandorf B; Herman L; Aguilera J; Andryszkiewicz M; Gomes A; Kovalkovicova N; Liu Y; Rainieri S; Chesson A
    EFSA J; 2021 Oct; 19(10):e06851. PubMed ID: 34721697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guidance on the scientific requirements for health claims related to muscle function and physical performance: (Revision 1).
    ; Turck D; Castenmiller J; De Henauw S; Hirsch-Ernst KI; Kearney J; Knutsen HK; Maciuk A; Mangelsdorf I; McArdle HJ; Naska A; Pelaez C; Pentieva K; Thies F; Tsabouri S; Vinceti M; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Neuhäuser-Berthold M; Nowicka G; Sanz Y; Sjödin A; Stern M; Tomé D; Van Loveren H; Willatts P; Martin A; Strain JJ; Heng L; Valtueña Martínez S; Siani A
    EFSA J; 2018 Oct; 16(10):e05434. PubMed ID: 32625715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scientific Guidance on the data required for the risk assessment of flavourings to be used in or on foods.
    ; Younes M; Aquilina G; Castle L; Degen G; Fowler PJ; Fernandez MJF; Fürst P; Gundert-Remy U; Gürtler R; Husøy T; Manco M; Mennes W; Moldeus P; Passamonti S; Shah R; Waalkens-Berendsen I; Wölfle D; Wright M; Benigni R; Bolognesi C; Boon P; Chipman K; De Knecht J; Nørby K; Arcella D; Barmaz S; Carfì M; Laganaro M; Martino C; Tard A; Vianello G; Engel KH
    EFSA J; 2022 Dec; 20(12):e07673. PubMed ID: 36579172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment and Management of Health Claims in Europe 9 Years after the Adoption of the Regulation.
    Martin A
    J Nutr Sci Vitaminol (Tokyo); 2015; 61 Suppl():S50-2. PubMed ID: 26598885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scientific Guidance for the preparation of applications on smoke flavouring primary products.
    ; Younes M; Aquilina G; Castle L; Fowler P; Frutos Fernandez MJ; Fürst P; Gundert-Remy U; Gürtler R; Husøy T; Manco M; Mennes W; Moldeus P; Passamonti S; Shah R; Waalkens-Berendsen I; Wölfle D; Wright M; Benigni R; Bolognesi C; Boon P; Chipman K; De Knecht J; Sahlin U; Arcella D; Barmaz S; Carfì M; Martino C; Tard A; Vianello G; Engel KH
    EFSA J; 2021 Mar; 19(3):e06435. PubMed ID: 33717353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scientific substantiation of health claims in the EU.
    Flynn A
    Proc Nutr Soc; 2012 Feb; 71(1):120-6. PubMed ID: 21933455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guidance for the scientific requirements for health claims related to antioxidants, oxidative damage and cardiovascular health: (Revision 1).
    ; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Sjödin A; Stern M; Tomé D; Van Loveren H; Vinceti M; Willatts P; Martin A; Strain JJ; Heng L; Valtueña Martínez S; Siani A
    EFSA J; 2018 Jan; 16(1):e05136. PubMed ID: 32625682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vibigaba (germinated brown rice) and maintenance of long-term normal blood glucose concentration: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006.
    ; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Sjödin A; Stern M; Tomé D; Van Loveren H; Vinceti M; Willatts P; Martin A; Strain JJ; Siani A
    EFSA J; 2017 Jul; 15(7):e04916. PubMed ID: 32625576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vibigaba (germinated brown rice) and maintenance of normal blood pressure: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006.
    ; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Sjödin A; Stern M; Tomé D; Van Loveren H; Vinceti M; Willatts P; Martin A; Strain JJ; Siani A
    EFSA J; 2017 Jul; 15(7):e04914. PubMed ID: 32625574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vibigaba (germinated brown rice) and maintenance of normal blood cholesterol concentration: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006.
    ; Turck D; Bresson JL; Burlingame B; Dean T; Fairweather-Tait S; Heinonen M; Hirsch-Ernst KI; Mangelsdorf I; McArdle HJ; Naska A; Neuhäuser-Berthold M; Nowicka G; Pentieva K; Sanz Y; Sjödin A; Stern M; Tomé D; Van Loveren H; Vinceti M; Willatts P; Martin A; Strain JJ; Siani A
    EFSA J; 2017 Jul; 15(7):e04913. PubMed ID: 32625573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.